News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Ipilimumab and Nivolumab for patients with unresected advanced Hepatocellular Carcinoma – ESMO
Photo from ESMO/LinkedIn
Jul 5, 2024, 02:30

Ipilimumab and Nivolumab for patients with unresected advanced Hepatocellular Carcinoma – ESMO

ESMO shared on LinkedIn:

“Benefits reported for the combination of ipilimumab and nivolumab further expand alternative therapeutic options for patients with unresected advanced Hepatocellular Carcinoma.
Read the opinion piece by Angela Lamarca on ESMO Daily Reporter.”

Source: ESMO/LinkedIn

.

Angela Lamarca cancer ESMO ESMO Daily Reporter hepatocellular carcinoma ipilimumab nivolumab OncoDaily Oncology
Special Coverage
Blog
Jun 19, 2025, 11:53
Yakup Ergün: Ivonescimab (PD-1 × VEGF) and Tarlatamab (DLL3 × CD3) are My Favorites Drugs For Lung Cancer - Even Better Ones Are Yet to Come
Blog
Jun 19, 2025, 10:28
Enrique Soto Perez de Celis on the Global Mission of CU Cancer Center's International Fellowship Program
Insight
Jun 19, 2025, 09:48
Nicholas Hornstein: Watching the Center of Gravity in Oncology Drug Development Move
Blog
Jun 19, 2025, 09:37
Majority of Americans Oppose Cuts to Medical Research Funding - AACR
Positive
Jun 19, 2025, 09:29
Margaret Foti: Great to See Riccardo Dalla-Favera at ICML 2025
Insight
Jun 19, 2025, 09:24
Alberto Puccini and Massimo Di Maio Shared Report on Patient-Reported Outcomes in BMJ Oncology
Opinion
Jun 19, 2025, 09:23
Debra Patt: The Power of Advocacy in Transforming Cancer Care
Positive
Jun 19, 2025, 09:21
Estela Rodriguez: Recording Educational Video on Dato-DXd for EGFR-Mutated NSCLC with ReachMD
Science
Jun 19, 2025, 09:07
Myeloma Paper of the Day, June 19th, suggested by Robert Orlowski
Blog
Jun 19, 2025, 08:57
Yüksel Ürün: Transparent Peer Review Is Now Standard for All Research Papers
Insight
Jun 19, 2025, 08:39
Charles Jiang: Fascinating Insights on Timing of Checkpoint Inhibitor Infusions from ASCO25
Blog
Jun 19, 2025, 08:34
Registration Is Open for The 2025 Chicago Cholangiocarcinoma Symposium - Cholangiocarcinoma Foundation